Home > Insider Trading > Filing (0001123292-13-001403)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1175505	Five Prime Therapeutics Inc	FPRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1266567	G Brian Atwood	C/O Five Prime Therapeutics, Inc. Two Corporate Drive South San Francisco CA 94080		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-09-23	986,240	$0.00	986,240	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2013-09-23	28,989	$0.00	1,015,229	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2013-09-23	76,923	$13.00	1,092,152	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2013-09-23	986,240	$0.00	986,240	$0.00
Common Stock	Series A-2 Preferred Stock	Disposition	2013-09-23	28,989	$0.00	28,989	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

Immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of convertible preferred stock automatically converted into one share of common stock. The convertible preferred stock had no expiration date.
The securities are owned directly by Versant Affiliates Fund I-A, L.P., Versant Affiliates Fund I-B, L.P., Versant Side Fund I, L.P. and Versant Venture Capital I, L.P (collectively, the "Versant Entities"). Mr. Atwood is a managing member of Versant Ventures I, L.L.C., the general partner of each of the Versant Entities, and may be deemed to have shared voting and dispositive power over the shares owned by the Versant Entities. Mr. Atwood disclaims beneficial ownership of all shares held by the Versant Entities, except to the extent of his actual pecuniary interest therein.